Plus: OpenAI has paused some model work over safety concerns. This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world of technology.

AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...

Recent episodes of AI agents escaping test zones and hacking other systems may be a harbinger of what's to come, as some experts believe the systems are fundamentally unpredictable.

Recursion Partners with Genentech to Advance First Validated Neuro Target Discovered Through AI Map By Alex Philippidis, GEN Edge, Aug 5, 2026 COVID-19 Reactivates Dormant Viruses, Offering New Clues ...

As AI makes coding dramatically faster, the next big challenge in software development is testing and validating all that code. Blacksmith has raised a new $45 million round to capitalize on that ...

Forbes contributors publish independent expert analyses and insights. Analyzing tech stocks through the prism of cultural change. This voice experience is generated by AI. Learn more. This voice ...

Recursion Pharmaceuticals, Inc. remains a Hold as competitive advances and slow revenue growth challenge its AI-driven drug discovery ambitions. RXRX's partnerships, notably with Genentech/Roche and ...

SpaceX recently valued the AI code editor Cursor at $60 billion, marking an unprecedented rise in enterprise software valuation. This signals a venture capital shift, prioritizing judgment and ...

Cloud providers such as Microsoft, Google, and Amazon sell compute capacity. Affordable tokens from a variety of model makers increase demand for that compute while reducing reliance on a select few, ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...